ARCHIVES

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

This article is from The Cancer Letter archive.

Vol. 39 No. 05 | February 1, 2013

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Von Eschenbach’s Proposal for Plan B Fails to Impress Democrats, Angers Social Conservatives.

August 4, 2006

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

No Cancer Letter For Next Two Weeks

August 30, 1991

PNIH Says New Env. Care Study Section On The Way

February 3, 1978

In Brief: Three, Perhaps Four May Be Recommended To Carter; Hugh Creech To Retire July 1

April 1, 1977